Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Aegis and Phylogica collaborate to deliver intranasal Phylomer peptide drugs

April 14, 2009

BioWa licenses Potelligent Technology to sanofi-aventis

April 9, 2009

Merck KGaA and Yissum sign agreement to develop semiconductor nanoparticles

April 2, 2009

Ono and Xention sign drug discovery agreement targeting ion channels

March 13, 2009

Xencor and Pfizer sign technology licensing agreement for Xtend and XmAb

March 3, 2009

ImmunoVaccine signs agreement with NIH for its DepoVax vaccine enhancement system

Feb. 27, 2009

Opsona signs collaboration agreement with CSL in infectious diseases and oncology

Feb. 25, 2009

Xencor and CSL sign antibody optimization collaboration including access to XmAb

Feb. 25, 2009

Flamel and Merck Serono sign license agreement to apply Medusa technology to therapeutic protein

Feb. 18, 2009

Drug delivery innovation: Selective release of DNA oligonucleotides from gold nanorods with lasers

Feb. 3, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...